Susan E. Bates
Impact in
- Oncology top 0.02%
- Drug Transport and Resistance Mechanisms
- Cancer Cells and Metastasis
- Cancer Research top 0.5%
Papers in
- Oncology 281
- Drug Transport and Resistance Mechanisms 157
- Pancreatic and Hepatic Oncology Research 29
-
- Histone Deacetylase Inhibitors Research 62
- Cancer therapeutics and mechanisms 55
- Epigenetics and DNA Methylation 26
- Co-authors
- Tito Fojo (94 shared papers)Michael M. Gottesman (10 shared papers)Robert W. Robey (110 shared papers)Michael C. Dean (15 shared papers)Antonio Tito Fojo (36 shared papers)Thomas Litman (27 shared papers)Richard Piekarz (46 shared papers)Orsolya Polgár (19 shared papers)
- Journals
- Clinical Cancer Research (49 papers)The Oncologist (31 papers)Blood (21 papers)Cancer Research (17 papers)Seminars in Oncology (12 papers)
- Partner nations
- United StatesUnited KingdomIsrael
In The Last Decade
Susan E. Bates
448 papers receiving 42.6k citations
Susan E. Bates's Hit Papers
Peers
Comparison fields: 5 of 192
- Oncology 23.5k
- Cancer Research 4.2k
- Molecular Biology 20.6k
- Pediatrics, Perinatology and Child Health 4.2k
- Pharmacology 1.5k
Countries citing papers authored by Susan E. Bates
This map shows the geographic impact of Susan E. Bates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan E. Bates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan E. Bates more than expected).
Fields of papers citing papers by Susan E. Bates
This network shows the impact of papers produced by Susan E. Bates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan E. Bates. The network helps show where Susan E. Bates may publish in the future.
Co-authors
The 25 scholars most cited alongside Susan E. Bates, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 462 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Multidrug resistance in cancer: role of ATP–dependent transporters Hit paper breakdown → | 2002 | 4813 |
| 2 | Tumour stem cells and drug resistance Hit paper breakdown → | 2005 | 3153 |
| 3 | Revisiting the role of ABC transporters in multidrug-resistant cancer Hit paper breakdown → | 2018 | 1503 |
| 4 | An Information-Intensive Approach to the Molecular Pharmacology of Cancer Hit paper breakdown → | 1997 | 1021 |
| 5 | Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Hit paper breakdown → | 1999 | 715 |
| 6 | Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2023 | 699 |
| 7 | The Role of ABC Transporters in Clinical Practice Hit paper breakdown → | 2003 | 685 |
| 8 | 2009 | 632 | |
| 9 | From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance Hit paper breakdown → | 2001 | 595 |
| 10 | 2003 | 536 | |
| 11 | Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms. | 2002 | 463 |
| 12 | 2000 | 461 | |
| 13 | 2011 | 409 | |
| 14 | 1988 | 405 | |
| 15 | 2001 | 394 | |
| 16 | 2008 | 386 | |
| 17 | 1990 | 378 | |
| 18 | Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma Hit paper breakdown → | 2020 | 370 |
| 19 | Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells. | 2001 | 369 |
| 20 | Epigenetic Therapies for Cancer Hit paper breakdown → | 2020 | 358 |
About Susan E. Bates
Susan E. Bates is a scholar working on Oncology, Molecular Biology, Cancer Research, Pediatrics, Perinatology and Child Health and Dermatology, having authored 462 papers that have together received 44.0k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (157 papers), Histone Deacetylase Inhibitors Research (62 papers), Cancer therapeutics and mechanisms (55 papers), Pharmacological Effects and Toxicity Studies (43 papers), Pancreatic and Hepatic Oncology Research (29 papers), HIV/AIDS drug development and treatment (26 papers), Epigenetics and DNA Methylation (26 papers) and Cancer Genomics and Diagnostics (25 papers). The work is most often cited by research in Oncology (23.5k citations), Cancer Research (4.2k citations), Molecular Biology (20.6k citations), Pediatrics, Perinatology and Child Health (4.2k citations) and Pharmacology (1.5k citations). Susan E. Bates has collaborated with scholars based in United States, United Kingdom and Israel. Frequent co-authors include Tito Fojo, Michael M. Gottesman, Robert W. Robey, Michael C. Dean, Antonio Tito Fojo, Thomas Litman, Richard Piekarz, Orsolya Polgár, Wilfred Donald Stein and Zhirong Zhan. Their work appears in journals such as Clinical Cancer Research, The Oncologist, Blood, Cancer Research and Seminars in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.